SPPI
Income statement / Annual
Last year (2022), Spectrum Pharmaceuticals, Inc.'s total revenue was $10.11 M,
and the percentage change from the previous year is not available.
In 2022, Spectrum Pharmaceuticals, Inc.'s net income was -$78.10 M.
See Spectrum Pharmaceuticals, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
| Operating Revenue |
$10.11 M |
$0.00 |
$0.00 |
$22.62 M |
$109.33 M |
$128.37 M |
$146.44 M |
$162.56 M |
$186.83 M |
$155.85 M |
| Cost of Revenue |
$1.79 M
|
$0.00
|
$0.00
|
$12.01 M
|
$26.76 M
|
$47.22 M
|
$35.84 M
|
$27.69 M
|
$27.04 M
|
$28.58 M
|
| Gross Profit |
$8.32 M
|
$0.00
|
$0.00
|
$10.61 M
|
$82.58 M
|
$81.15 M
|
$110.60 M
|
$134.87 M
|
$159.79 M
|
$127.27 M
|
| Gross Profit Ratio |
0.82
|
0
|
0
|
0.47
|
0.76
|
0.63
|
0.76
|
0.83
|
0.86
|
0.82
|
| Research and Development Expenses |
$42.20 M
|
$87.30 M
|
$109.38 M
|
$79.33 M
|
$94.96 M
|
$65.90 M
|
$58.94 M
|
$50.77 M
|
$69.66 M
|
$46.67 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$38.82 M
|
$60.41 M
|
$60.36 M
|
$61.37 M
|
$90.70 M
|
$84.27 M
|
$87.35 M
|
$86.51 M
|
$97.41 M
|
$99.32 M
|
| Other Expenses |
-$5.33 M
|
-$10.89 M
|
-$2.94 M
|
-$8.89 M
|
$9.58 M
|
$389,000.00
|
$887,000.00
|
-$1.25 M
|
-$4.37 M
|
-$722,000.00
|
| Operating Expenses |
$81.02 M
|
$147.70 M
|
$169.73 M
|
$140.70 M
|
$213.75 M
|
$177.81 M
|
$172.23 M
|
$175.60 M
|
$191.36 M
|
$166.06 M
|
| Cost And Expenses |
$82.81 M
|
$147.70 M
|
$169.73 M
|
$140.70 M
|
$240.51 M
|
$225.03 M
|
$208.07 M
|
$203.29 M
|
$218.40 M
|
$194.64 M
|
| Interest Income |
$968,000.00
|
$163,000.00
|
$1.34 M
|
$5.00 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$998,000.00
|
$0.00
|
$0.00
|
-$5.00 M
|
$340,000.00
|
$6.80 M
|
$9.44 M
|
$9.07 M
|
$8.58 M
|
$2.19 M
|
| Depreciation & Amortization |
-$4.36 M
|
$286,000.00
|
$261,000.00
|
$3.34 M
|
$28.10 M
|
$27.65 M
|
$25.95 M
|
$38.32 M
|
$24.29 M
|
$20.07 M
|
| EBITDA |
-$77.06 M |
-$147.70 M |
-$169.73 M |
-$140.70 M |
-$93.50 M |
-$68.62 M |
-$34.80 M |
-$3.66 M |
-$11.65 M |
-$21.58 M |
| EBITDA Ratio |
-7.62
|
0
|
0
|
-6.22
|
-0.86
|
-0.53
|
-0.24
|
-0.02
|
-0.06
|
-0.14
|
| Operating Income Ratio |
-7.19
|
0
|
0
|
-6.37
|
-1.2
|
-0.75
|
-0.42
|
-0.25
|
-0.17
|
-0.25
|
| Total Other Income/Expenses Net |
-$5.36 M
|
-$10.73 M
|
-$1.60 M
|
$174.20 M
|
$11.17 M
|
-$11.37 M
|
-$9.20 M
|
-$9.65 M
|
-$11.96 M
|
$2.15 M
|
| Income Before Tax |
-$78.06 M
|
-$158.43 M
|
-$171.33 M
|
-$144.59 M
|
-$120.01 M
|
-$108.03 M
|
-$70.83 M
|
-$50.38 M
|
-$43.53 M
|
-$36.64 M
|
| Income Before Tax Ratio |
-7.72
|
0
|
0
|
-6.39
|
-1.1
|
-0.84
|
-0.48
|
-0.31
|
-0.23
|
-0.24
|
| Income Tax Expense |
$46,000.00
|
$4,000.00
|
-$60,000.00
|
-$9.21 M
|
$1,000.00
|
-$16.78 M
|
-$2.31 M
|
$406,000.00
|
$2.19 M
|
$25.50 M
|
| Net Income |
-$78.10 M
|
-$158.44 M
|
-$171.27 M
|
-$135.39 M
|
-$120.01 M
|
-$91.25 M
|
-$68.51 M
|
-$50.79 M
|
-$45.72 M
|
-$62.13 M
|
| Net Income Ratio |
-7.72
|
0
|
0
|
-5.99
|
-1.1
|
-0.71
|
-0.47
|
-0.31
|
-0.24
|
-0.4
|
| EPS |
-0.43 |
-1.02 |
-1.38 |
-1.22 |
-1.16 |
-1.07 |
-0.94 |
-0.78 |
-0.71 |
-1.02 |
| EPS Diluted |
-0.43 |
-1.02 |
-1.38 |
-1.22 |
-1.16 |
-1.07 |
-0.94 |
-0.78 |
-0.71 |
-1.02 |
| Weighted Average Shares Out |
$183.24 M
|
$154.86 M
|
$124.39 M
|
$110.59 M
|
$103.31 M
|
$85.12 M
|
$72.82 M
|
$64.88 M
|
$64.71 M
|
$60.73 M
|
| Weighted Average Shares Out Diluted |
$183.24 M
|
$154.86 M
|
$124.39 M
|
$110.59 M
|
$103.31 M
|
$85.12 M
|
$72.82 M
|
$64.88 M
|
$64.71 M
|
$60.73 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
